Literature DB >> 15050641

Sulfonyl-phenyl-ureido benzamidines; a novel structural class of potent antimalarial agents.

Johann Leban1, Stefano Pegoraro, Matthias Dormeyer, Michael Lanzer, Andrea Aschenbrenner, Bernd Kramer.   

Abstract

The high throughput in silico screening of a virtual library into the structure of the P. falciparum lactate dehydrogenase (LDH) with the 4SCan technology yielded a series of biphenyl urea compounds. These were chemically optimized to a new structural class of potent antimalarial agents. The compounds did not inhibit plasmodium LDH enough to fully explain their potency. Therefore we conclude that an unknown mode of action may be the cause of the antimalarial activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050641     DOI: 10.1016/j.bmcl.2004.01.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Identification of novel phenyl butenonyl C-glycosides with ureidyl and sulfonamidyl moieties as antimalarial agents.

Authors:  K Kumar G Ramakrishna; Sarika Gunjan; Akhilesh Kumar Shukla; Venkata Reddy Pasam; Vishal M Balaramnavar; Abhisheak Sharma; Swati Jaiswal; Jawahar Lal; Renu Tripathi; Ravishankar Ramachandran; Rama Pati Tripathi
Journal:  ACS Med Chem Lett       Date:  2014-06-02       Impact factor: 4.345

2.  Evaluation of Diarylureas for Activity Against Plasmodium falciparum.

Authors:  Yiqun Zhang; Marc Anderson; Jennifer L Weisman; Min Lu; Cindy J Choy; Vincent A Boyd; Jeanine Price; Martina Sigal; Julie Clark; Michele Connelly; Fangyi Zhu; W Armand Guiguemde; Cynthia Jeffries; Lei Yang; Andrew Lemoff; Ally P Liou; Thomas R Webb; Joseph L Derisi; R Kiplin Guy
Journal:  ACS Med Chem Lett       Date:  2010-12-09       Impact factor: 4.345

3.  Novel diaryl ureas with efficacy in a mouse model of malaria.

Authors:  John W Anderson; Dimitri Sarantakis; Jacek Terpinski; T R Santha Kumar; Han-Chun Tsai; Mack Kuo; Arba L Ager; William R Jacobs; Guy A Schiehser; Sean Ekins; James C Sacchettini; David P Jacobus; David A Fidock; Joel S Freundlich
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

4.  SC83288 is a clinical development candidate for the treatment of severe malaria.

Authors:  Stefano Pegoraro; Maëlle Duffey; Thomas D Otto; Yulin Wang; Roman Rösemann; Roland Baumgartner; Stefanie K Fehler; Leonardo Lucantoni; Vicky M Avery; Alicia Moreno-Sabater; Dominique Mazier; Henri J Vial; Stefan Strobl; Cecilia P Sanchez; Michael Lanzer
Journal:  Nat Commun       Date:  2017-01-31       Impact factor: 14.919

5.  Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes.

Authors:  Nubia Boechat; Luiz C S Pinheiro; Osvaldo A Santos-Filho; Isabor C Silva
Journal:  Molecules       Date:  2011-09-20       Impact factor: 4.411

6.  New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety.

Authors:  D I Ugwuja; U C Okoro; S S Soman; R Soni; S N Okafor; D I Ugwu
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.